Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

PAVmed Inc diskutieren

PAVmed Inc

WKN: A2AQDJ / Symbol: PAVM / Name: PAVmed / Aktie / Ausrüstung & Versorgung / Micro Cap /

0,20 €
-12,07 %

Einschätzung Buy
Rendite (%) -
Kursziel 19,03
Veränderung
Endet am 10.09.25

PAVmed Inc. (NASDAQ: PAVM) had its price target lowered by analysts at Ascendiant Capital Markets from $22.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for PAVM provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 17,96
Veränderung
Endet am 09.12.25

PAVmed Inc. (NASDAQ: PAVM) had its price target lowered by analysts at Ascendiant Capital Markets from $21.00 to $19.00. They now have a "buy" rating on the stock.
Ratings data for PAVM provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 16,99
Veränderung
Endet am 21.04.26

PAVmed Inc. (NASDAQ: PAVM) had its price target raised by analysts at Ascendiant Capital Markets from $19.00 to $19.50. They now have a "buy" rating on the stock.
Ratings data for PAVM provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 16,60
Veränderung
Endet am 06.06.26

PAVmed Inc. (NASDAQ: PAVM) had its price target lowered by analysts at Ascendiant Capital Markets from $19.50 to $19.00. They now have a "buy" rating on the stock.
Ratings data for PAVM provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 17,06
Veränderung
Endet am 06.10.26

PAVmed (NASDAQ:PAVM) had its price target raised by analysts at Ascendiant Capital Markets from $19.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for PAVM provided by MarketBeat

PAVmed (NASDAQ:PAVM) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for PAVM provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 14,60
Veränderung
Endet am 10.12.26

PAVmed (NASDAQ:PAVM) had its price target lowered by analysts at Ascendiant Capital Markets from $20.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for PAVM provided by MarketBeat